Is there a role for post-treatment PET/CT following chemoRT for Stage III NSCLC?  

The NCCN guidelines discourage the use of PET/CT surveillance but the recent analysis of RTOG 0235 found post-CRT PET uptake to be associated with worse LRC. Is this something we should be looking at in order to select out patients for early salvage therapy?



Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Academic Institution

Answer from: Radiation Oncologist at Community Practice